Yang JL - Search Results

1

[Expressions of human epidermal growth factor receptor 2 and vascular endothelial growth factor in primary or recurrent metastatic breast cancers].

Wang ZK, Meng HY, Han C, Yang JL. Wang ZK, et al. Among authors: yang jl. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):403-6. doi: 10.3881/j.issn.1000-503X.2010.04.009. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20868598 Chinese.

2

[Gene expression profiling of nasopharyngeal carcinoma cell line 5-8F-EGFP and the liver metastatic 5-8F-H3B-EGFP cells].

HAN C, YANG JL, YAO KT. HAN C, et al. Among authors: yang jl. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar;31(3):473-7. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21421486 Chinese.

3

Regulatory T cells increase in breast cancer and in stage IV breast cancer.

Wang ZK, Yang B, Liu H, Hu Y, Yang JL, Wu LL, Zhou ZH, Jiao SC. Wang ZK, et al. Among authors: yang jl, yang b. Cancer Immunol Immunother. 2012 Jun;61(6):911-6. doi: 10.1007/s00262-011-1158-4. Epub 2011 Nov 25. Cancer Immunol Immunother. 2012. PMID: 22116346 Free PMC article.

4

Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells.

Li Y, Shi L, Han C, Wang Y, Yang J, Cao C, Jiao S. Li Y, et al. Tumour Biol. 2012 Oct;33(5):1403-10. doi: 10.1007/s13277-012-0388-1. Epub 2012 Apr 14. Tumour Biol. 2012. PMID: 22528939

5

[Effects of single versus combined use of trastuzumab and cantide on breast cancer cells SKBR3 over-expressing HER2].

Zhang F, Yang JL, You JH, Feng F, Ren L, Xie WX, Li ZJ. Zhang F, et al. Among authors: yang jl. Zhonghua Yi Xue Za Zhi. 2012 May 29;92(20):1384-7. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22883194 Chinese.

6

[Prognostic value of T lymphocytes infiltration in breast cancer].

Yu HM, Jiao SC, Yang JL, Wang JD. Yu HM, et al. Among authors: yang jl. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):199-206. doi: 10.3881/j.issn.1000-503X.2013.02.013. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23643010 Chinese.

7

[Prognostic value of B lymphocyte infiltration in breast cancer].

Yu H, Yang J, Jiao S, Wang J. Yu H, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2013 May;33(5):750-5. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 23689000 Chinese.

8

Effects of ARHI on breast cancer cell biological behavior regulated by microRNA-221.

Li Y, Liu M, Zhang Y, Han C, You J, Yang J, Cao C, Jiao S. Li Y, et al. Tumour Biol. 2013 Dec;34(6):3545-54. doi: 10.1007/s13277-013-0933-6. Epub 2013 Jun 26. Tumour Biol. 2013. PMID: 23801152

9

[Clinical paired study of comparing docetaxel plus capecitabine versus docetaxel plus epirubicin as first-line treatment in women with HER-2 negative advanced breast cancer].

Yang B, Yang JL, Shi WW, Liu H, Zhu YY, Fang P, Ji TF. Yang B, et al. Among authors: yang jl. Zhonghua Yi Xue Za Zhi. 2013 May 14;93(18):1397-400. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24025504 Clinical Trial. Chinese.

10

[Prognostic value of IL-10 expression in tumor tissues of breast cancer patients].

Li Y, Yu H, Jiao S, Yang J. Li Y, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 May;30(5):517-20. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 24796749 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,415 results

Search Page

Filters